China Vitamin Industry Report, 2012-2015
  • Apr.2013
  • Hard Copy
  • USD $1,900
  • Pages:73
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code: ZYM041
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,800
  • Hard Copy + Single User License
  • USD $2,100
As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of the total output in the same period; moreover, it holds a leading position worldwide in both production technology and market share of vitamin C, vitamin E, vitamin A, vitamin B2, etc..

However, due to the impact of the economic downturn in Europe and the United States, China’s future vitamin market will face grim situation, especially exports even see further decline. Vitamin output in 2013-2015 is expected to be around 220,000-280,000 tons, of which, export volume will make up 75%-80%.

China’s Vitamin Output and Export Volume, 2009-2012

In 2012, China’s VC production capacity accounted for 80%-90% of the global total, leading enterprises includeded CSPC Pharmaceutical Group Limited ( referred to as “CSPC Pharma”), North China Pharmaceutical Group Corp. (“NCPC”), Northeast Pharmaceutical Group Co., Ltd (NEPG), Aland (Jiangsu) Nutraceutical Co., Ltd., Shandong Luwei Pharmaceutical Co., Ltd., whose annual capacity all exceeded 15,000 tons; VA occupied 40%-50%, main companies referred to Zhejiang NHU Co.,Ltd., (12,000 tons/a) and Zhejiang Medicine Co.,Ltd. (11,000 tons/a); VE shared more than 50%, chiefly produced by Zhejiang Medicine Co.,Ltd., Zhejiang NHU Co.,Ltd, and Southwest Synthetic Pharmaceutical Corp., Ltd.. Nevertheless, Chinese export-oriented products are mostly used as feed additives, the discourse power of high-end product prices still lies in the hands of foreign companies such as DSM and BASF.

As the international economic environment remained in the doldrums, in 2012, China’s vitamin products export growth slowed down, VC, VE, VA and other single species saw a general decline in export volume. While B1, B5 (calcium pantothenate), B6, etc. in B vitamins still maintained a good momentum, whose export volume reached 5260 tons (up 3.6% YoY), 9642 tons (up 6.2% YoY) and 4487 tons (up 26.6% YoY), but also with average export prices lifted to varying degrees .

China Vitamin Industry Report, 2012-2015 of ResearchInChina mainly covers the followings:
20120114.gif?International market, development status, competition pattern, imports & exports, prospect forecast, etc. of China vitamin industry;
20120114.gif Current development , imports & exports, market price, etc. of China vitamin A, vitamin B, vitamin C, vitamin E and other market segments;
20120114.gif Operation, vitamin business, prospect forecast, etc. of two global and seven Chinese companies.

1. Overview of Vitamin
1.1 Definition 
1.2 Classification

2. Development of China Vitamin Industry
2.1 International Market
2.2 Current Development
2.3 Competition Pattern
2.4 Imports & Exports
2.4.1 Exports
2.4.2 Imports
2.5 Prospect & Forecast

3. China Vitamin Industry Segments
3.1 VA
3.1.1 Development
3.1.2 Imports & Exports
3.1.3 Market Price
3.2 VB
3.2.1 D- or DL-Pantothenic Acid (VB3 or VB5)
3.2.2 VB6
3.2.3 VB1
3.2.4 VB2
3.2.5 Choline Chloride (VB4)
3.2.6 VB12
3.3 VC
3.3.1 Development 
3.3.2 Imports & Exports
3.3.3 Market Price
3.4 VE
3.4.1 Development
3.4.2 Imports & Exports
3.4.3 Market Price
3.5 Others

4. Key Companies
4.1 North China Pharmaceutical Group Corp.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Main Clients
4.1.5 Vitamin Business
4.1.6 Prospect & Forecast
4.2 CSPC Pharmaceutical Group Limited
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Vitamin Business
4.2.5 Prospect & Forecast
4.3 Zhejiang Medicine Co.,Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Vitamin Business
4.3.5 Prospect & Forecast
4.4 Zhejiang NHU Co.Ltd
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Main Clients
4.4.5 Vitamin Business
4.4.6 Prospect & Forecast
4.5 Southwest Synthetic Pharmaceutical Corp., Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Vitamin Business
4.5.5 Prospect & Forecast
4.6 Brother Enterprises Holding Co.,Ltd.
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Main Clients
4.6.5 Vitamin Business
4.6.6 Prospect & Forecast
4.7 Zhejiang Hangzhou Xinfu Pharmaceutical Co.,Ltd
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 Vitamin Business
4.7.6 Prospect & Forecast
4.8 Foreign Companies
4.8.1 Disiman Vitamin (Shanghai) Co., Ltd
4.8.2 BASF Vitamins Company Ltd.
Classification and Function of Vitamin
Structure of the World’s Vitamin Consumption (by Application)
Proportion of Essential Vitamins in Various Application Areas
China’s Vitamin Output and Export Volume, 2009-2012
China’s Vitamin Export Volume, Value and Average Price, 2009-2012
China’s Vitamin Export Volume Structure (by Product), 2009-2012
China’s Top 20 Vitamin Export Countries and Regions (by Export Volume), 2012
China’s Vitamin Import Volume, Value and Average Price, 2010-2012
China’s Vitamin Import Volume Structure (by Product), 2010-2012
China’s Top 20 Vitamin Import Countries and Regions (by Import Volume), 2012
China’s Vitamin Exports As a Percentage of Output, 2012-2015E
Output of China’s Leading Vitamin Companies, 2011
China’s VA Export Volume, Value and Average Price, 2009-2012
China’s Top 10 VA Export Countries and Regions (by Export Volume), 2012
China’s VA Import Volume, Value and Average Price, 2009-2012
China’s Top 10 VA Import Countries and Regions, 2012
China’s VA Market Price Trend, 2009-2013
China’s D- or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5) Export Volume, Value and Average Price, 2009-2012
China’s D- or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5) Import Volume, Value and Average Price, 2009-2012
China’s Calcium Pantothenate (VB5) Market Price, 2009-2013
China’s Niacin (VB3) Market Price, 2009-2013
China’s VB6 Export Volume, Value and Average Price, 2009-2013
China’s VB6 Market Price, 2009-2013
Output and Export Volume of China’s Leading VB1 and Derivatives Manufacturers, 2011
China’s VB1 Export Volume, Value and Average Price, 2009-2013
China’s VB1 Market Price, 2009-2013
China’s VB2 Export Volume, Value and Average Price, 2009-2012
China’s VB2 (80%) Market Price, 2009-2013
China’s Choline Chloride Export Country Structure (by Export Volume), 2010-2012
China’s Choline Chloride (VB4) Market Price, 2009-2013
China’s VB12 Export Volume, Value and Average Price, 2009-2012
China’s VB12 (Liquid Phase 1%) Market Price, 2009-2013
Output of China’s Leading VC Companies, 2011
China’s VC Export Volume, Value and Average Price, 2009-2012
China’s Top 20 VC Export Countries and Regions, 2012
China’s VC Import Volume, Value and Price, 2009-2012
China’s Top 10 VC Import Countries and Regions, 2012
China’s VC Market Price Trend, 2009-2013
Output of China’s Leading VE Companies, 2011
China’s VE Export Volume, Value and Average Price, 2009-2012
China’s Top 10 VE Export Countries and Regions (by Export Volume), 2012
China’s VE Import Volume, Value and Average Price, 2009-2012
China’s Top 10 VE Import Countries and Regions, 2012
China’s VE Market Price Trend, 2009-2013
Output and Export Volume of China’s Small Breed Vitamin Manufacturers, 2011 (Part)
Revenue and Net Income of NCPC, 2009-2012
Operating Revenue of NCPC by Product, 2009-2012
Operating Revenue of NCPC by Region, 2009-2012
Name List and Revenue Contribution of NCPC’s Top 5 Clients, 2011-2012
Vitamin Related Subsidiaries of NCPC
Vitamin Output and Export Volume of NCPC (by Product), 2011
Revenue and Operating Income of NCPC’s Vitamin Business, 2009-2012
Operating Margin of NCPC’s Vitamin Business, 2009-2012
Revenue and Profit of NCPC, 2012-2015
Holding (Joint Venture) Companies of China Pharmaceutical
Revenue and Gross Profit of CSPC Pharma, 2009-2012
Operating Revenue and Profit of CSPC Pharma by Product, 2010-2012
Revenue of CSPC Pharma by Region, 2010-2012
Vitamin Output and Export Volume of CSPC Pharma by Product, 2011
Revenue and Profit of CSPC Pharma’s VC Business, 2010-2012
Revenue and Net Income of CSPC Pharma, 2011-2015
Revenue and Net Income of Zhejiang Medicine, 2009-2012
Revenue of Zhejiang Medicine by Product, 2009-2012
Vitamin Output and Export Volume of Zhejiang Medicine by Product, 2011
Revenue and Net Income of Zhejiang Medicine, 2011-2015E
Revenue and Profit of Zhejiang NHU, 2009-2012
Revenue of Zhejiang NHU by Product, 2009-2012
Operating Revenue of Zhejiang NHU by Region, 2009-2012
Name List and Revenue Contribution of Zhejiang NHU’s Top 5 Clients, 2011
Vitamin Revenue and Operating Income of Zhejiang NHU by Product, 2009-2012
Vitamin Output and Export Volume of Zhejiang NHU by Product, 2011
Revenue and Operating Income of Zhejiang NHU, 2011-2015E
Revenue and Net Income of Southwest Synthetic Pharmaceutical, 2009-2012
Operating Revenue of Southwest Synthetic Pharmaceutical by Product, 2009-2012
Operating Revenue of Southwest Synthetic Pharmaceutical by Region, 2009-2012
VE Output and Export Volume of Southwest Synthetic Pharmaceutical, 2011
Revenue and Net Income of Southwest Synthetic Pharmaceutical, 2011-2015
Revenue and Net Income of Brother Enterprises, 2009-2012
Operating Revenue of Brother Enterprises by Product, 2009-2012
Gross Margin of Brother Enterprises by Product, 2009-2012
Operating Revenue of Brother Enterprises by Region, 2009-2012
Name List and Revenue Contribution of Brother Enterprises’ Top 5 Clients, 2010-2012
Revenue of Brother Enterprises’ Vitamin Business by Product, 2009-2012
Vitamin Gross Margin of Brother Enterprises by Product, 2009-2012
Revenue and Net Income of Brother Enterprises, 2011-2015E
Revenue and Net Income of Xinfu Pharmaceutical, 2009-2012
Revenue and Operating Income of Xinfu Pharmaceutical by Product, 2009-2012
Gross Margin of Xinfu Pharmaceutical by Product, 2009-2012
Vitamin Revenue and Gross Margin of Xinfu Pharmaceutical by Product, 2009-2012
Revenue and Net Income of Xinfu Pharmaceutical, 2011-2015E 

China Contract Research Organization (CRO) Industry Report, 2020-2026

The contract research organization (CRO) industry has been galloping amid the global pharmaceutical market steadily in head way, the vibrant financing in the medical and health sector, and the prolife...

China Human Vaccine Industry Report, 2020-2026

In China, the lot release for human vaccines plunged by 17.7% in 2018 when the production record fraud of rabies vaccines for human use, freeze-dried by Changsheng Bio-Technology was exposed. The impa...

China Pharmaceutical Distribution Industry Report, 2019-2026

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号